No-Cost, No-Obligation
Talcum Powder
Ovarian Cancer
Lawsuit Case Review

Talcum Powder Cancer Lawsuit Center

Who Can File a Talcum Powder Ovarian Cancer Lawsuit?

RECENT TALCUM POWDER AND OVARIAN CANCER NEWS

Talcum Powder Ovarian Cancer Lawsuit News

St Louis Law Firm Wins Lawsuit Case Against Johnson and Johnson

Johnson and Johnson guilty of putting profits ahead of the health and safety of the public

Friday, July 14, 2017 - In a landmark decision and after a three-week trial, people around the world are only now being warned that there is a link between a product they use every day and the "skyrocketing rate of ovarian cancer." The son of deceased Alabama woman Jacqueline Fox was awarded $72 million as compensation holding Johnson & Johnson responsible for her death. Ms. Fox, who was too ill to attend the trial, testified in a recorded deposition that she had used Johnson & Johnson's Baby Powder and Shower to Shower Body Powder for feminine hygiene for her entire adult life and that she was "raised up on it." Ms. Fox, who died in October 2015, three years after first being diagnosed with ovarian cancer, testified that using the products was the part of her daily routines like deodorant or toothpaste. She was only 59-years old at the time of her death and left a son and two foster children.

In a St. Louis, Missouri courtroom, plaintiffs alleged that for decades Johnson & Johnson had covered up their knowledge of studies by reputable third-party sources that linked their best-selling talcum powder products with incidents of ovarian cancer in women. At trial, the attorneys for Ms. Fox, The Onder Law firm, presented evidence that the Johnson & Johnson products in question were not only responsible for causing Jacqueline Fox's ovarian cancer but also that Johnson & Johnson was keenly aware of this fact and not only did not disclose their knowledge in the form of updating their product warning, but instead chose to redirect their marketing efforts toward African American women, which they considered a less-educated and less-sophisticated demographic. As a result, millions of women around the world have been exposed to the deadly carcinogenic effects of using Johnson's Baby Powder in the genital region as studies have proven talc particles over time migrate up a women's fallopian tubes and become lodged in the ovaries causing inflammation and eventually cancer. Jurors went on record after the trial as well saying that damning internal correspondence depicting the talcum powder/cancer link cover up, the company's racist redirecting their marketing efforts, and also its willful deception in failing to warn the public with a clear product warning label update in order to protect their brand, weighed heavy in their decision against the pharmaceutical giant. One juror, Krista Smith said, "It was really clear they were hiding something," referring to marketing executives at Johnson & Johnson."

This is not the first time that Johnson & Johnson has been guilty of putting profits ahead of the health and safety of the public. In 2012 the company was forced to remove formaldehyde, used by morticians as an embalming fluid, from Johnson's "No More Tears" baby shampoo after consumer groups complained about the product. Formaldehyde is considered a "probable carcinogenic". The International Agency for Research on Cancer classifies talc as possibly carcinogenic when used on a woman's genital area. Johnson & Johnson has also been forced to recall medications such as Tylenol, Motrin, and Benadryl after it did not fully meet the required manufacturing specifications.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation.